首页> 外国专利> SINGLE NUCLEOTIDE POLYMORPHISM MARKER OF HSD11B1 ALLELE FOR PREDICTION AND DIAGNOSIS OF RISK IN OSTEOPOROSIS AND OSTEOPOROTIC COMPRESSION

SINGLE NUCLEOTIDE POLYMORPHISM MARKER OF HSD11B1 ALLELE FOR PREDICTION AND DIAGNOSIS OF RISK IN OSTEOPOROSIS AND OSTEOPOROTIC COMPRESSION

机译:HSD11B1等位基因的单核苷酸多态性标记,用于预测和诊断骨质疏松和骨质疏松症的风险

摘要

PURPOSE: A HSD11B1 polymorphysm marker for predicting and diagnosing osteoporosis and osteoporotic fracture is provided to develop a kit for predicting and diagnosing osteroporosis. CONSTITUTION: A HSD11B1 polymorphism marker is used for predicting and diagnosing osteoporosis and osteroporotic fracture. The polymorphism marker has polymorphism of -19835GA, +16374GA, +27447GC or haplotype thereof. A method or predicting and diagnosing risk of osteoporosis and osteoporotic fracture comprises: a step of detecting polymorphic site of HSD11B1 gene from DNA extracted from a sample; and a step of analyzing relation between detected polymorphic site and osteoporosis phenotype change. A kit for predicting and diagnosing osteoporosis and osteoporotic fracture contains a primer set which amplifies polymorphic site of HSD11B1 gene, molecular weight marker, amplifying enzyme, nucleotide, and buffer.
机译:目的:提供一种用于预测和诊断骨质疏松和骨质疏松性骨折的HSD11B1多态性标记物,以开发用于预测和诊断骨质疏松症的试剂盒。组成:HSD11B1多态性标志物可用于预测和诊断骨质疏松和骨质疏松性骨折。多态性标记具有-19835G> A,+ 16374G> A,+ 27447G> C或其单倍型的多态性。一种预测或诊断骨质疏松症和骨质疏松性骨折风险的方法,包括:从样品中提取的DNA检测HSD11B1基因的多态性位点的步骤。分析多态性位点与骨质疏松症表型变化之间关系的步骤。用于预测和诊断骨质疏松症和骨质疏松性骨折的试剂盒包含一个引物组,可扩增HSD11B1基因的多态性位点,分子量标记,扩增酶,核苷酸和缓冲液。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号